Emergency atrial fibrillation patients invited to study
Part of Heart & circulation clinical trials.
This study includes people who have atrial fibrillation and are seen in the emergency department. It aims to learn from emergency care and may help improve how atrial fibrillation is managed in the ER.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for atrial fibrillation in the Emergency Department at the Medical University of Vienna
- You can and will sign the study consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study looks at how to better judge a person’s risk of developing atrial fibrillation, a type of irregular heartbeat. You may help researchers by completing interviews and assessments that guide future risk estimates.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
This study sets up a research “platform” to improve and compare care for people having atrial fibrillation (an irregular heartbeat) treated with ablation. Some patients may be asked for extra imaging or heart-mapping tests during their care, and your eligibility may depend on which extra tests are offered.
This study looks at what results from atrial fibrillation ablation (a heart rhythm procedure) and newer related therapies. If you recently had the procedure—or are scheduled for it soon—you may use an app and website to share information that helps researchers compare outcomes and improve care.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.